Kidney Cancer :: A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.